Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.322
Buy
RSI(14)
57.048
Neutral
STOCH(KDJ)(9,3,3)
73.983
Neutral
ATR(14)
1.367
Low Volatility
CCI(14)
106.989
Buy
Williams %R
30.521
Buy
TRIX(12,20)
0.046
Sell
StochRSI(14)
50.679
Sell
Artivion Inc
AORT46.600USD
-0.550-1.17%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
2.21BMarket Cap
LossP/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Artivion Inc
Currency: USD Updated: 2025-12-19Key Insights
Artivion Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 2/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 51.71.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Artivion Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
7
analysts
Buy
Current Rating
51.714
Target Price
+17.35%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Artivion Inc Highlights
StrengthsRisks
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 23.82% year-on-year.
Undervalued
The company’s latest PE is -201.94, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 43.29M shares, increasing 0.07% quarter-over-quarter.
Held by Joel Greenblatt
Star Investor Joel Greenblatt holds 14.72K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.99.
Financial Health
Currency: USD Updated: 2025-12-19The current financial score of Artivion Inc is 8.62, ranking 32/208 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 113.39M, representing a year-over-year increase of 18.39%, while its net profit experienced a year-over-year increase of 384.25%.
Score
Financials
7.21
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
10.00
Operational Efficiency
9.31
Growth Potential
9.13
Shareholder Returns
7.42
Artivion Inc's Company Valuation
Currency: USD Updated: 2025-12-19The current valuation score of Artivion Inc is 7.37, ranking 95/208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -201.94, which is -91.28% below the recent high of -17.61 and -591.69% above the recent low of -1396.83.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 2/208
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2025-12-19The current earnings forecast score of Artivion Inc is 8.29, ranking 50/208 in the Healthcare Equipment & Supplies industry. The average price target for Artivion Inc is 53.00, with a high of 58.00 and a low of 40.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
7
analysts
Buy
Current Rating
51.714
Target Price
+17.35%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
112
Total
6
Median
9
Average
Company name
Ratings
Analysts
Artivion Inc
AORT
7
Medtronic PLC
MDT
35
Stryker Corp
SYK
32
Abbott Laboratories
ABT
31
Dexcom Inc
DXCM
31
Zimmer Biomet Holdings Inc
ZBH
30
1
2
3
...
23
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-12-19The current price momentum score of Artivion Inc is 9.18, ranking 24/208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 48.97 and the support level at 43.40, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
46.432
Buy
MA10
45.429
Buy
MA20
45.597
Buy
MA50
44.797
Buy
MA100
42.831
Buy
MA200
35.131
Buy
Institutional Confidence
Currency: USD Updated: 2025-12-19The current institutional shareholding score of Artivion Inc is 10.00, ranking 1/208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 91.25%, representing a quarter-over-quarter decrease of 0.27%. The largest institutional shareholder is The Vanguard, holding a total of 3.02M shares, representing 6.38% of shares outstanding, with 1.77% decrease in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
Fidelity Management & Research Company LLC
Nomura Investment Management Business Trust
Perceptive Advisors LLC
Morgan Stanley Smith Barney LLC
State Street Investment Management (US)
Wellington Management Company, LLP
Juniper Investment Company, LLC
Fred Alger Management, LLC
1
2
Risk Assessment
Currency: USD Updated: 2025-12-19The current risk assessment score of Artivion Inc is 8.39, ranking 22/208 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.57. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.
Score
Beta vs S&P 500 index
1.57
VaR
+3.74%
240-Day Maximum Drawdown
+30.00%
240-Day Volatility
+41.23%
Return
Best Daily Return
60 days
+4.18%
120 days
+25.23%
5 years
+25.23%
Worst Daily Return
60 days
-5.54%
120 days
-5.54%
5 years
-28.05%
Sharpe Ratio
60 days
+2.06
120 days
+2.02
5 years
+0.51
Risk Assessment
Maximum Drawdown
240 days
+30.00%
3 years
+30.00%
5 years
+68.86%
Return-to-Drawdown Ratio
240 days
+2.24
3 years
+2.61
5 years
+0.25
Skewness
240 days
+4.12
3 years
+2.03
5 years
+0.69
Volatility
Realised Volatility
240 days
+41.23%
5 years
+44.05%
Standardised True Range
240 days
+2.34%
5 years
+1.74%
Downside Risk-Adjusted Return
120 days
+523.22%
240 days
+523.22%
Maximum Daily Upside Volatility
60 days
+18.42%
Maximum Daily Downside Volatility
60 days
+23.39%
Liquidity
Average Turnover Rate
60 days
+0.98%
120 days
+1.04%
5 years
--
Turnover Deviation
20 days
+99.26%
60 days
+36.24%
120 days
+44.12%
Peer Comparison
Healthcare Equipment & Supplies
Artivion Inc
AORT
8.59 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Edwards Lifesciences Corp
EW
8.61 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LIVN
8.59 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
LNTH
8.57 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Tactile Systems Technology Inc
TCMD
8.43 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AXGN
8.40 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
FAQs
How does TradingKey generate the Stock Score of Artivion Inc?
The TradingKey Stock Score provides a comprehensive assessment of Artivion Inc based on 34 indicators derived from over 100 underlying data points. These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Artivion Inc’s performance and outlook.
How do we generate the financial health score of Artivion Inc?
To generate the financial health score of Artivion Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns. By integrating these comprehensive data, the financial health score not only reflects Artivion Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Artivion Inc.
How do we generate the company valuation score of Artivion Inc?
To generate the company valuation score of Artivion Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Artivion Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value. By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Artivion Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Artivion Inc.
How do we generate the earnings forecast score of Artivion Inc?
To calculate the earnings forecast score of Artivion Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.Comparing these indicators against peers provides context for the stock’s performance and helps
anchor more realistic expectations.These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Artivion Inc’s future.
How do we generate the price momentum score of Artivion Inc?
When generating the price momentum score for Artivion Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.This comprehensive approach can reflect market sentiment and enable rational forecasts of Artivion Inc’s prices. A higher score indicates a more stable short-term price trend for Artivion Inc.
How do we generate the institutional confidence score of Artivion Inc?
To generate the institutional confidence score of Artivion Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Artivion Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Artivion Inc.
How do we generate the risk management score of Artivion Inc?
To assess the risk management score of Artivion Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.These indicators together provide a multi-dimensional understanding of Artivion Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Artivion Inc.
